Cargando…
Amygdalin potentiates the anti-cancer effect of Sorafenib on Ehrlich ascites carcinoma and ameliorates the associated liver damage
The burden of cancer diseases is increasing every year, therefore, the demands to figure out novel drugs that can retain antitumor properties have been raised. This study aimed to investigate the anti-tumor properties of amygdalin (Amy) against Ehrlich ascites carcinoma (EAC) bearing mice and its pr...
Autores principales: | Attia, Attia Ahmed, Salama, Afrah Fatthi, Eldiasty, Jayda G., Mosallam, Sahar Abd El-Razik, El-Naggar, Sabry Ali, El-Magd, Mohammed Abu, Nasser, Hebatala M., Elmetwalli, Alaa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021277/ https://www.ncbi.nlm.nih.gov/pubmed/35444229 http://dx.doi.org/10.1038/s41598-022-10517-0 |
Ejemplares similares
-
Hepatocellular Carcinoma cells: activity of Amygdalin and Sorafenib in Targeting AMPK /mTOR and BCL-2 for anti-angiogenesis and apoptosis cell death
por: El-Sewedy, Tarek, et al.
Publicado: (2023) -
Thymoquinone, piperine, and sorafenib combinations attenuate liver and breast cancers progression: epigenetic and molecular docking approaches
por: El-Shehawy, Ashraf A., et al.
Publicado: (2023) -
Diarylheptanoids/sorafenib as a potential anticancer combination against hepatocellular carcinoma: the p53/MMP9 axis of action
por: Elmetwalli, Alaa, et al.
Publicado: (2023) -
Modulation of the oxidative damage, inflammation, and apoptosis-related genes by dicinnamoyl-L-tartaric acid in liver cancer
por: Elmetwalli, Alaa, et al.
Publicado: (2023) -
Evaluation of Bacillus aryabhattai B8W22 peroxidase for phenol removal in waste water effluents
por: Elmetwalli, Alaa, et al.
Publicado: (2023)